GreenVolts and NREL to Collaborate on Commercialization of IMM Multi-Junction Solar Cell Technology

GreenVolts, a leader in concentrating photovoltaic technology, today announced that it has entered into a development relationship with the National Renewable Energy Laboratory (NREL) to commercialize the Inverted Metamorphic (IMM) advanced multi-junction solar cell design. The Department of Energy has committed $500,000 for GreenVolts to co-develop NREL's patents and bring this new technology to market. Additionally, GreenVolts has signed a licensing agreement with NREL to commercialize their patents.

The purpose of this two-year agreement is to transfer NREL's IMM solar cell technology to GreenVolts so that the company can develop a customized cell tailored to its optical system, and accelerate the widespread commercialization of the technology through its high volume manufacturing partners. The development agreement will be completed in multiple phases, each of which will build towards GreenVolts delivering a customized, reliable IMM device cost effectively fabricated at high volume.

"We believe this new IMM technology is key to a tremendous leap forward in solar cell efficiency," NREL Director Dan Arvizu said. "We are pleased to be working with GreenVolts to both refine these advancements and provide for a viable way to bring them to market."

The NREL IMM technology has demonstrated one of the world's highest reported solar cell efficiencies at 40.8 percent, and holds the promise for even further substantial increases. A customized solar cell will enable GreenVolts to optimize its concentrating photovoltaic system by increasing efficiency and reliability while reducing the overall cost of energy.

"This is an exciting opportunity to make significant advancements in the performance of solar cell technology," said Bob Cart, founder and CEO of GreenVolts. "We look forward to working closely with NREL to develop a quality high volume, low cost manufacturing process to ensure that this next generation technology will be readily available."

Under a Cooperative Research and Development Agreement (CRADA), technical representatives from both parties cooperate to make important technical advancements. Throughout the CRADA, NREL will provide necessary technology specifications and process information as well as advice and assistance in the device optimization and technology transfer. NREL will also provide test and measurement services to qualify the results of the transfer process, including its reliability.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.